NCT05601271

Effect of Allopurinol on Markers of Mineral and Bone Metabolism

CompletedNAINTERVENTIONAL

Trial Details

Start: 2021-03-01Est. Completion: 2025-03-01

Enrollment target: 50 participants

Locations

Chronic Kidney DiseaseType 2 Diabetes Mellitus

Availability of this study's data will later be determined according to Bayer's commitment to the EFPIA/PhRMA "Principle…

Multiple Locations, IndiaEst. completion Jun 30, 2026

Kidney Transplant AccessObese PatientsDialysisComorbidities

Obesity is in constant increase all over the world and affects 35% of the global population according to the World Healt…

Amiens, FranceEst. completion Jun 2026

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.